Skip to main content

Table 5 Linear regression (enter) analysis of factors influencing anxiety, depression, and post-traumatic stress disorder scores* over time in Omani children and adolescents diagnosed with cancer (N = 92)

From: Prevalence of anxiety, depression, and post-traumatic stress disorder among Omani children and adolescents diagnosed with cancer: a prospective cross-sectional study

Variable

Anxiety

Depression

PTSD

β

p value

β

p value

β

p value

First assessment (T1)

      

Age

0.762

< 0.001†

0.460

0.001†

-0.197

0.193

Age group

-0.217

0.001†

-0.113

0.091

0.119

0.107

Cancer risk‡

-

-

-0.038

0.565

0.147

0.025†

Awareness of diagnosis

0.074

0.170

-

-

0.079

0.204

Cancer stage

-

-

0.061

0.257

-

-

Anxiety score

-

-

0.098

0.391

0.287

0.016†

Depression score

0.099

0.348

-

-

0.604

< 0.001†

PTSD score

0.209

0.025†

0.488

< 0.001†

-

-

Adjusted R2

0.861

0.849

0.827

Second assessment (T2)

      

Age

0.553

< 0.001†

0.297

0.018†

-0.180

0.155

Age group

-0.134

0.014†

-0.004

0.957

0.096

0.159

Cancer risk‡

0.061

0.224

0.106

0.093

-0.039

0.541

Awareness of diagnosis

0.003

0.946

0.017

0.770

0.047

0.419

Anxiety score

-

-

0.143

0.290

0.622

< 0.001†

Depression score

0.091

0.290

-

-

0.426

< 0.001†

PTSD score

0.400

< 0.001†

0.431

< 0.001†

-

-

Adjusted R2

0.896

0.837

0.839

  1. Abbreviation: PTSD: Post-Traumatic Stress Disorder. *The presence of anxiety, depression, and PTSD symptoms was assessed using validated Arabic versions of the Screen for Child Anxiety Related Disorders, Center for Epidemiologic Studies Depression Scale for Children, and Impact of Event Scale-Revised instruments, respectively. Scores of ≥ 25, ≥15, and ≥ 33, respectively, were considered indicative of an anxiety disorder, depressive symptoms, and a probable diagnosis of PTSD [15,16,17,18,19,20]. †Considered statistically significant at p ≤ 0.05. ‡Estimated based on the participant’s age at diagnosis, disease stage, tumour histology, MYCN status (amplified versus nonamplified), and tumour cell ploidy status [21]